# Treatment of Women With Hyperandrogenic PCOS With Two Different Ratios of Myo-inositol:D-chiro-inositol: A Comparison

> **NCT06715527** · NA · COMPLETED · sponsor: **Lo.Li.Pharma s.r.l** · enrollment: 30 (actual)

## Conditions studied

- Polycystic Ovarian Syndrome (PCOS)

## Interventions

- **DIETARY_SUPPLEMENT:** Myo-Inositol and D-Chiro-Inositol (40:1)
- **DIETARY_SUPPLEMENT:** Myo-Inositol and D-Chiro-Inositol (3.6:1)

## Key facts

- **NCT ID:** NCT06715527
- **Lead sponsor:** Lo.Li.Pharma s.r.l
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-01
- **Primary completion:** 2025-03-06
- **Final completion:** 2025-03-14
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06715527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06715527, "Treatment of Women With Hyperandrogenic PCOS With Two Different Ratios of Myo-inositol:D-chiro-inositol: A Comparison". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06715527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*